Thermo Fisher Scientific (TMO) Key Ratios
$609.82
As on 11-Sep-2026 16:14EDT
Market cap
$223,024 Mln
Revenue (TTM)
$46,336 Mln
P/E Ratio
32.6
P/B Ratio
4.3
Div. Yield
0.3 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 8.99 | 10.49 | 7.23 | 2.11 | 3.91 |
| EBIT | 11.01 | -1.23 | 1.20 | 6.03 | -3.82 |
| Net Profit | 5.16 | 7.18 | 5.67 | 9.15 | -3.78 |
| EPS | 5.72 | 9.38 | 7.77 | 8.38 | -2.92 |
| Book Value | -- | -- | 9.42 | 8.18 | 10.43 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 18.59 | 19.75 | 18.62 | 19.49 | 20.27 |
| Net Margin
| -- | 17.76 | 15.06 | -- | -- |
| Return on equity
| 13.15 | 15.27 | 13.12 | 13.08 | 13.15 |
| Return on Capital
| 7.56 | 8.61 | -- | 7.69 | 7.65 |
| Return on Assets
| 6.36 | 7.14 | 5.76 | 6.49 | 6.46 |
| Debt to Equity (x)
| -- | -- | 0.74 | 0.74 | 0.66 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
13.12
Higher than Peers by 8.14
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
13.12
|
13.08
|
13.15
|
13.22
|
16.40
|
20.52
|
|||||
|
Peer Median
|
4.98
|
--
|
--
|
--
|
--
|
--
|
ROA
5.76
Higher than Peers by 3.30
Profit after tax / Average Total assets * 100
EBIT Margin
18.62
Higher than Peers by 10.10
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
18.62
|
19.49
|
20.27
|
16.00
|
19.06
|
23.91
|
|||||
|
Peer Median
|
8.53
|
--
|
--
|
--
|
--
|
--
|
Net Margin
15.06
Higher than Peers by 10.31
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
15.06
|
15.12
|
14.77
|
13.99
|
15.48
|
20.04
|
|||||
|
Peer Median
|
4.75
|
--
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
Revenue Growth
7.23
Lower than Peers by 1.55
Year on year growth in net sales
EBIT Growth
1.20
Lower than Peers by 9.84
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
1.20
|
-0.07
|
26.72
|
-19.88
|
-8.70
|
20.48
|
|||||
|
Peer Median
|
11.03
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
5.67
Lower than Peers by 8.08
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
5.67
|
6.35
|
5.67
|
-13.74
|
-10.03
|
21.18
|
|||||
|
Peer Median
|
13.75
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
7.77
Lower than Peers by 13.67
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
7.77
|
0.08
|
0.07
|
-0.13
|
-0.09
|
0.22
|
|||||
|
Peer Median
|
21.44
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
6.26
Lower than Peers by 0.56
Year on year growth in book value per share
Solvency
Debt to Equity
0.74
Higher than Peers by 0.35
Total debt / Net worth
Short term debt to equity ratio
0.06
--
(Short term borrowings / Net worth)
Current Ratio
1.55
Lower than Peers by 1.15
Current Assets / Current Liabilities and Provisions
Quick Ratio
1.18
Lower than Peers by 0.85
(Current Assets - Inventory) / Current Liabilities and Provisions
Interest Coverage
6.19
Higher than Peers by 1.16
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
6.19
|
6.12
|
5.26
|
4.99
|
11.79
|
17.49
|
|||||
|
Peer Median
|
5.02
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
20.40
Higher than Peers by 4.01
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
20.40
|
23.71
|
22.45
|
22.55
|
20.99
|
22.81
|
|||||
|
Peer Median
|
16.39
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.38
Lower than Peers by 0.12
Sales / Average Total Assets
Receivable days
--
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
--
--
Average Creditors / Cost of goods sold * 365
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
Valuation
Price / Earnings
32.57
Lower than Peers by 13.52
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
32.57
|
32.43
|
31.45
|
34.35
|
31.14
|
34.38
|
|||||
|
Peer Median
|
46.09
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
4.25
Higher than Peers by 0.47
Current share price divided by book value per share in the latest financial year
Dividend Yield
0.30
--
Dividend per share in the past twelve months divided by current share price
EV/EBITDA
21.79
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
Market Cap
223,024
Higher than Peers by 222,489
Current Share price multiplied by latest total number of shares outstanding